NEWSROOM | Galderma

Galderma Announces Publication of Pivotal Phase 3 PERFECT 1 and PERFECT 2 Clinical Trials of Trifarotene in Patients with Moderate Facial and Truncal Acne in the Journal of the American Academy of Dermatology

Galderma: New data reveals benefits of combining oral and topical treatment in patients with severe papulopustular rosacea

Galderma Announces Formation of Women in Aesthetics Leadership Council

Nestlé Skin Health Opens Office in Malaysia

Galderma Announces New Collaborations with Top Aesthetic Professional Skincare Brands

International Dermatology Community Voting for the 2018 Galderma SKINPACT Awards

Galderma Announces FDA Approval of Restylane® Lyft For Midface Injection via Cannula

Galderma Partners with National Breast Cancer Foundation for 4th Annual Pink Day Event to Increase Breast Cancer Awareness

Galderma Announces Positive Results from Phase 2b Study of Nemolizumab in Patients with Moderate-to-Severe Atopic Dermatitis

Galderma Announces ASPIRE Rewards Program Reaches One Million Members

Women-Focused Biotech Takes Top Prize at Nestlé Skin Health SHIELD Pitch Event

Fort Worth’s Galderma, Maker of Cetaphil, Presents the 4th Annual Wonder Run 5K and 1K Kids Waddle to Benefit Children’s Skin Disease Foundation